脑脉通治疗脑动脉硬化症的临床观察

Clinical observation on Naomaitong in the treatment of cerebral arteriosclerosis

目的 观察脑脉通治疗脑动脉硬化症的临床疗效。方法 180例患者随机分为 2组 ,治疗组90例口服脑脉通 ,对照组 90例服用尼膜同。观察 2组临床疗效、脑血管多普勒超声血流图及血液流变变化。12周为 1个疗程。结果 治疗组总有效率为 88.9% ,对照组总有效率为 6 4 .4 % ,2组比较有显著性差异(P <0 .0 5 )。血液流变学变化 2组治疗后观察 ,均有显著性差异 (P <0 .0 5 )。

Objective To observe the therapeutic effect of Naomaitong on cerebral arteriosclerosis. Methods 180 patients with cerebral arteriosclerosis were randomly divided into two groups.90 patients in treatment group were treated by Naomaitong orally;the other 90 patients in control group were treated by nimotop, with a treatment course of 12 weeks for both groups. The clinical efficacy, hemorrheology changes and the changes of cerebrovascular Doppler ultrasonic hemotachogram were observed. Results The total effective rate (88.9%) in treatment group was significantly higher than that (64.4%) in control group(P<0.05).There was a significant difference in the changes of hemorrheology between two groups(P<0.05).Conclusion Naomaitong has a obvious therapeutic effect on cerebral arteriosclerosis.